{"schema_version":"secwatch.filing_event.v1","accession":"0001809519-25-000141","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.539216+00:00","generated_at":"2026-05-17T00:41:09.458286+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"GoodRx Q3 revenue $196M, net income $1.1M; raises manufacturer solutions outlook to ~35% growth","bullets":["Revenue of $196.0M; net income $1.1M (0.6% margin).","Adjusted EBITDA $66.3M (33.8% margin); Adjusted Net Income $28.8M (14.7% margin).","Raises Pharma Manufacturer Solutions revenue growth outlook to ~35% YoY for FY2025; maintains total revenue and adjusted EBITDA guidance.","Net cash from operations of $76.0M in Q3 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001809519-25-000141","json":"https://secwatch.observer/filing/0001809519-25-000141.json","markdown":"https://secwatch.observer/filing/0001809519-25-000141.md","text":"https://secwatch.observer/filing/0001809519-25-000141.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000180951925000141/0001809519-25-000141-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000180951925000141/gdrx-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:41:09.458286+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}